Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase III HARMONi-6 study (AK112-306) were shared in an oral ...

Somehow even I was surprised by the levels of shamelessness on display following the publication of the latest education statistics this ...

By Stella Qiu and Wayne Cole SYDNEY, Dec 3 (Reuters) - Australia's economy grew at the fastest annual pace in two years in ...

Capricor Therapeutics faces high regulatory risks for its DMD therapy. Get expert analysis on trial data and FDA challenges.

Patients who completed treatment by 12 months fared better than external controls 2 years ...

BGB-11417-202 ( NCT05479994) is an open-label, phase 2, and a potential registrational study evaluating the efficacy and safety of sonrotoclax in 100 heavily pretreated patients with R/R CLL/SLL. At a ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

The Adult Psychiatric Morbidity Survey provides the official statistics on trends over time in autism, psychotic disorder, ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

Fox Business host Dagen McDowell called out co-host Brian Brenberg during The Big Money Show, questioning his small business ...

Early results from Kyle’s housing assessment highlight affordability challenges for renters, homeowners and essential workers, with many households spending a large share of their income on housing.